|
|
J Z Melnick, P A Srere, N A Elshourbagy, O W Moe, P A Preisig, R J Alpern
J Clin Invest. 1996;
98(10):2381
doi:10.1172/JCI119051
Abstract |
Full text
| PDF

C
hronic metabolic acidosis increases proximal tubular citrate uptake and metabolism. The present study addressed the effect of chronic metabolic acidosis on a cytosolic enzyme of citrate metabolism, ATP citrate lyase. Chronic metabolic acidosis caused hypocitraturia in rats and increased renal cortical ATP citrate lyase activity by 67% after 7 d. Renal cortical ATP citrate lyase protein abundance increased by 29% after 3 d and by 141% after 7 d of acid diet. No significant change in mRNA abundance could be detected. Hypokalemia, which causes only intracellular acidosis, caused hypocitraturia and increased renal cortical ATP citrate lyase activity by 28%. Conversely, the hypercitraturia of chronic alkali feeding was associated with no change in ATP citrate lyase activity. Inhibition of ATP citrate lyase with the competitive inhibitor, 4S-hydroxycitrate, significantly abated hypocitraturia and increased urinary citrate excretion fourfold in chronic metabolic acidosis and threefold in K+-depletion. In summary, the hypocitraturia of chronic metabolic acidosis is associated with an increase in ATP citrate lyase activity and protein abundance, and is partly reversed by inhibition of this enzyme. These results suggest an important role for ATP citrate lyase in proximal tubular citrate metabolism.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(31)
| Title and authors |
Publication |
Year |
A metabonomic study of biochemical changes characteristic of genetically hypertensive rats based on 1H NMR spectroscopic urinalysis
Kazuki Akira, Shigenori Masu, Misako Imachi, Hidemichi Mitome, Takao Hashimoto
|
Hypertens Res
|
2011 |
Integrated metabolomic analysis of the nano-sized copper particle-induced hepatotoxicity and nephrotoxicity in rats: A rapid in vivo screening method for nanotoxicity
Ronghui Lei, Chunqi Wu, Baohua Yang, Huazhai Ma, Chang Shi, Quanjun Wang, Qingxiu Wang, Ye Yuan, Mingyang Liao
|
Toxicology and Applied Pharmacology
|
2008 |
Increased propensity for calcium phosphate kidney stones with topiramate use
Damaris Vega, Naim M Maalouf, Khashayar Sakhaee
|
Expert Opin. Drug Saf.
|
2007 |
Chronic acid ingestion promotes renal stone formation in rats treated with vitamin D3
Naohiko Okamoto, Seiji Aruga, Kyoichi Tomita, Takumi Takeuchi, Tadaichi Kitamura
|
International Journal of Urology
|
2007 |
Vitamin B6 deficiency augments endogenous oxalogenesis after intravenous l-hydroxyproline loading in rats
Y. Ogawa, R. Z. Hossain, T. Ogawa, K. Yamakawa, H. Yonou, Y. Oshiro, S. Hokama, M. Morozumi, A. Uchida, K. Sugaya
|
Urol Res
|
2007 |
Association of Prevalent Hypertension With 24-Hour Urinary Excretion of Calcium, Citrate, and Other Factors
Eric N. Taylor, David B. Mount, John P. Forman, Gary C. Curhan
|
American Journal of Kidney Diseases
|
2006 |
Medical Management of Recurrent Idiopathic Nephrolithiasis
Charles Y. C. Pak, Clarita V. Odvina
|
The Endocrinologist
|
2006 |
Na+/H+ exchangers in renal regulation of acid-base balance.
I Alexandru Bobulescu, Orson W Moe
|
Seminars in Nephrology
|
2006 |
Biochemical and Stone-Risk Profiles With Topiramate Treatment
Brian J. Welch, Dion Graybeal, Orson W. Moe, Naim M. Maalouf, Khashayar Sakhaee
|
American Journal of Kidney Diseases
|
2006 |
Dual role of citrate in mammalian urine
Orson W Moe, Patricia A Preisig
|
Current Opinion in Nephrology and Hypertension
|
2006 |
|